Analyzing the Global Women’s Health Care Market: Opportunities and Challenges

The Global Womens Healthcare Market size is projected to reach USD 17.8 billion by 2024, at a CAGR of 13.2%. The growth of the market is primarily driven by factors such as the growing incidence of chronic health conditions among women, government initiatives to curb population growth, and growing demand for contraceptives to prevent unintended pregnancies. Moreover, the growing focus on R&D by key players for the development of advanced products is also a major factor in driving market growth.

Download PDF Brochure:

Key Players

Bayer AG (Germany), Allergan (Dublin), Merck & Co. (US), Pfizer Inc. (US), Amgen (US), Agile Therapeutics Inc. (US), Ferring Pharmaceuticals (US), Mylan N.V. (US), Lupin (India), Blairex Laboratories (US), and Apothecus Pharmaceutical (US).

Amgen (US): Amgen (US) is one of the leading providers of the women’s healthcare market. The company’s sales and marketing activities are greatly focused on the US and Europe. The company provides Prolia and Xgeva for the treatment of osteoporosis in postmenopausal women. These drugs have shown a year-on-year double-digit value gain as well as volume growth, and constitute the largest share of the market. Amgen’s EVENITY, meant for the treatment of osteoporosis in postmenopausal women, is also in phase 3 of development. It is being developed in collaboration with UCB (Belgium). The company’s high brand recognition and focus on product innovation have helped it to maintain its foothold in the market.

Eli Lilly and Company (US)

Eli Lilly is one of the leading players in the women’s healthcare market. The company provides EVISTA and FORTEO for the treatment of postmenopausal osteoporosis. The company’s vast geographical presence is one of its key strengths and gives the company a competitive advantage over other players. The company operates in around 120 countries across North America, Latin America, Europe, Eastern Europe, the Middle East, Africa, and the Asia Pacific, with manufacturing units located in 13 countries. The company mainly focuses on product innovation.

Women’s Healthcare Market Dynamics

Market Growth Drivers

  • Growing Incidence of Chronic Health Conditions Among Women
  • Demand for Contraceptives to Prevent Unintended Pregnancies
  • Government Initiatives to Curb Population Growth
  • Growing Focus on Product R&D

Market Growth Opportunities

  • Emerging Markets
  • Development of Innovative Technologies

Market Challenges

  • Reluctance to Use Contraceptives
  • Lack of Access to Quality Care

Request 10% Customization:

North America accounted for the largest share of the women’s healthcare industry in 2019.

The global women’s healthcare market is segmented into five major regions, namely, North America, Europe, APAC, Latin America, and the Middle East & Africa. In 2018, North America (US and Canada) was the largest and the fastest-growing regional market for women’s healthcare. The major factors supporting market growth include the growing prevalence of PCOS and postmenopausal osteoporosis, increasing median age of first-time pregnancies, and increased healthcare spending in the US and Canada. Also, the high awareness and understanding regarding contraceptives among American women and the easy access to modern contraception as compared to developing countries propel the market growth in this region.

Report Objectives

  • To define, describe, and forecast the women’s healthcare market on the basis of drug, application, and region
  • To provide detailed information regarding the major factors influencing the growth of the market (such as drivers, opportunities, and challenges)
  • To analyze the micromarkets with respect to individual growth trends, prospects, and contributions to the overall market
  • To analyze the opportunities for stakeholders and provide details of the competitive landscape for market leaders
  • To forecast the size of the market segments with respect to five main regions, namely, North America, Europe, Asia Pacific (APAC), Latin America, and the Middle East & Africa
  • To profile the key players and analyze their market shares and core competencies
  • To track and analyze competitive developments such as product launches; partnerships, agreements, & collaborations; expansions & strategic alliances; and acquisitions in the market
  • To benchmark players within the market using the proprietary “Competitive Leadership Mapping” framework, which analyzes market players on various parameters within the broad categories of business and product excellence strategy

Related Links: